GABA supplements have not been linked to liver damage in any published clinical trial or case report. A comprehensive safety review by the United States Pharmacopeia found no serious adverse events associated with GABA at doses up to 18 grams per day for four days, and no clinically relevant changes in blood chemistry (which includes liver enzyme markers) in participants taking repeated doses. The typical supplement contains 500 to 750 mg, a fraction of the amounts tested without harm.
What the Safety Data Actually Shows
GABA has been tested in humans at doses ranging from 0.25 mg to 18,000 mg per day across studies lasting four days to 12 weeks. In one study where participants took 2 grams three times daily for seven days, researchers found no clinically relevant changes in vital signs, blood work, or physical examination. The side effects that did show up were minor: sore throat, a temporary burning sensation after swallowing the powder, headache, drowsiness, and occasional abdominal discomfort. None were classified as serious.
Longer-term data is more limited. The longest controlled study used 120 mg per day for 12 weeks and reported no serious adverse effects. That dose is well below what most supplements provide, so there’s a gap in our knowledge about what happens with higher doses taken over many months. But nothing in the existing research raises a red flag for liver toxicity specifically.
How Your Liver Handles GABA
Your liver is actually the primary organ responsible for breaking down GABA you swallow. It contains high levels of an enzyme called GABA-transaminase, which appears to act as a gatekeeper, neutralizing dietary or supplemental GABA before it can reach the brain. This system is so efficient that even when researchers fed animals a diet containing 2% GABA by weight, blood levels of GABA barely budged. Even at 5% GABA in the diet (an enormous amount), blood levels rose by only about 2% compared to controls.
This means your liver rapidly processes oral GABA as part of its normal function. There is no evidence that this process strains the liver or generates toxic byproducts. GABA is not metabolized through the cytochrome P450 system, the set of liver enzymes responsible for breaking down most drugs and the pathway most commonly involved in drug-induced liver injury.
GABA May Actually Protect the Liver
Several animal studies suggest GABA has anti-inflammatory effects in liver tissue. In a 60-day study on pigs, dietary GABA supplementation increased the activity of antioxidant enzymes in the liver and reduced levels of pro-inflammatory signaling molecules like TNF-alpha and IL-1beta. Researchers observed less inflammatory cell infiltration in liver tissue from supplemented animals compared to controls.
Separate research in rats found that GABA administration improved liver function and reduced insulin resistance, a key driver of fatty liver disease. These findings are preliminary and come from animal models, so they don’t translate directly to human health claims. But they point in the opposite direction of liver harm.
The Gabapentin Confusion
If your search turned up scary-sounding case reports about liver injury, you may have encountered studies about gabapentin, a prescription medication. Gabapentin is sometimes described as a “GABA analogue” because its chemical structure loosely resembles GABA, but it works through completely different mechanisms in the body. A small number of case reports have documented gabapentin-induced liver injury, with liver enzymes returning to normal after the drug was stopped. This has nothing to do with GABA supplements. The two are distinct substances with different pharmacology.
Practical Considerations
Most GABA supplements on the market contain between 250 mg and 750 mg per serving, which falls well within the range tested without adverse effects in clinical studies. The mild side effects that do occur, like drowsiness or stomach discomfort, are dose-dependent and more common at gram-level doses.
One important caveat: GABA supplements are not regulated with the same rigor as pharmaceuticals. Contamination, mislabeling, or the inclusion of undisclosed ingredients in poorly manufactured products could theoretically pose risks that have nothing to do with GABA itself. Choosing a product that has been independently tested by a third-party organization like USP or NSF helps reduce that concern.
For people with existing liver conditions like cirrhosis or advanced fatty liver disease, there is essentially no published research evaluating GABA supplement safety in that specific population. The liver’s ability to metabolize GABA efficiently depends on having functional liver tissue, so it’s reasonable to be more cautious if your liver function is already compromised.